Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$2.89−0.11 (-3.67%)
Close on Nov 12, 2026Market cap $121.74MP/E –Yield –
Apyx Medical total assets
Total assets on the balance sheet at the end of each period.
Apyx Medical's total assets was $61.67M at Sep 30, 2026. For fiscal 2025 it was $66.84M, up 3.1% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $95.93M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.84M | +3.1% |
| FY2024 | Dec 31, 2024 | $64.84M | -18.2% |
| FY2023 | Dec 31, 2023 | $79.24M | +53.0% |
| FY2022 | Dec 31, 2022 | $51.78M | -24.7% |
| FY2021 | Dec 31, 2021 | $68.72M | -7.3% |
| FY2020 | Dec 31, 2020 | $74.11M | -12.5% |
| FY2019 | Dec 31, 2019 | $84.75M | -11.7% |
| FY2018 | Dec 31, 2018 | $95.93M | +209.6% |
| FY2017 | Dec 31, 2017 | $30.99M | -11.7% |
| FY2016 | Dec 31, 2016 | $35.11M | +11.6% |
| FY2015 | Dec 31, 2015 | $31.45M | +26.6% |
| FY2014 | Dec 31, 2014 | $24.83M | -25.1% |
| FY2013 | Dec 31, 2013 | $33.18M | +17.7% |
| FY2012 | Dec 31, 2012 | $28.18M | -0.2% |
| FY2011 | Dec 31, 2011 | $28.24M | +1.6% |
| FY2010 | Dec 31, 2010 | $27.79M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $61.67M | +7.5% |
| Q2 FY2026 | Jun 30, 2026 | $61.07M | +5.0% |
| Q1 FY2026 | Mar 31, 2026 | $63.03M | +4.8% |
| Q4 FY2025 | Dec 31, 2025 | $66.84M | +3.1% |
| Q3 FY2025 | Sep 30, 2025 | $57.37M | -5.5% |
| Q2 FY2025 | Jun 30, 2025 | $58.19M | -11.0% |
| Q1 FY2025 | Mar 31, 2025 | $60.16M | -14.9% |
| Q4 FY2024 | Dec 31, 2024 | $64.84M | -18.2% |
| Q3 FY2024 | Sep 30, 2024 | $60.72M | +2.1% |
| Q2 FY2024 | Jun 30, 2024 | $65.39M | +4.7% |
| Q1 FY2024 | Mar 31, 2024 | $70.71M | +24.5% |
| Q4 FY2023 | Dec 31, 2023 | $79.24M | +53.0% |
| Q3 FY2023 | Sep 30, 2023 | $59.45M | +7.6% |
| Q2 FY2023 | Jun 30, 2023 | $62.43M | +5.0% |
| Q1 FY2023 | Mar 31, 2023 | $56.78M | -9.9% |
| Q4 FY2022 | Dec 31, 2022 | $51.78M | -24.7% |
| Q3 FY2022 | Sep 30, 2022 | $55.27M | -18.4% |
| Q2 FY2022 | Jun 30, 2022 | $59.47M | -14.5% |
| Q1 FY2022 | Mar 31, 2022 | $63.00M | -11.4% |
| Q4 FY2021 | Dec 31, 2021 | $68.72M | -7.3% |
| Q3 FY2021 | Sep 30, 2021 | $67.77M | -10.1% |
| Q2 FY2021 | Jun 30, 2021 | $69.60M | -10.6% |
| Q1 FY2021 | Mar 31, 2021 | $71.10M | -13.4% |
| Q4 FY2020 | Dec 31, 2020 | $74.11M | -12.5% |
| Q3 FY2020 | Sep 30, 2020 | $75.42M | -13.3% |
| Q2 FY2020 | Jun 30, 2020 | $77.83M | -12.4% |
| Q1 FY2020 | Mar 31, 2020 | $82.12M | -10.6% |
| Q4 FY2019 | Dec 31, 2019 | $84.75M | -11.7% |
| Q3 FY2019 | Sep 30, 2019 | $86.94M | -23.2% |
| Q2 FY2019 | Jun 30, 2019 | $88.88M | +190.0% |
| Q1 FY2019 | Mar 31, 2019 | $91.86M | +205.0% |
| Q4 FY2018 | Dec 31, 2018 | $95.93M | +209.6% |
| Q3 FY2018 | Sep 30, 2018 | $113.17M | +268.7% |
| Q2 FY2018 | Jun 30, 2018 | $30.65M | -5.8% |
| Q1 FY2018 | Mar 31, 2018 | $30.11M | -9.0% |
| Q4 FY2017 | Dec 31, 2017 | $30.99M | -11.7% |
| Q3 FY2017 | Sep 30, 2017 | $30.70M | – |
| Q2 FY2017 | Jun 30, 2017 | $32.56M | – |
| Q1 FY2017 | Mar 31, 2017 | $33.09M | – |
| Q4 FY2016 | Dec 31, 2016 | $35.11M | – |
See a number that looks wrong?